Descriptor English: | Alendronate | ||||
Descriptor Spanish: |
Alendronato
| ||||
Descriptor Portuguese: | Alendronato | ||||
Descriptor French: | Alendronate | ||||
Entry term(s): |
4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate Alendronate Monosodium Salt, Trihydrate Alendronate Sodium Aminohydroxybutane Bisphosphonate Fosamax MK 217 MK-217 MK217 |
||||
Tree number(s): |
D02.705.429.500.100 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D019386 | ||||
Scope note: | A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Bone Density Conservation Agents |
||||
Registry Number: | X1J18R4W8P | ||||
Previous Indexing: |
Diphosphonates (1987-1996) |
||||
Public MeSH Note: | 1997; ALENDRONATE was indexed under DIPHOSPHONATES 1987-1996 |
||||
History Note: | 1997 (1987) |
||||
DeCS ID: | 32988 | ||||
Unique ID: | D019386 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1997/01/01 | ||||
Date of Entry: | 1996/06/10 | ||||
Revision Date: | 2018/02/28 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Alendronate
- Preferred
MK-217
- Related but not broader or narrower
Alendronate Monosodium Salt, Trihydrate
- Narrower
Alendronate Sodium
- Narrower
Fosamax
- Related but not broader or narrower
Concept UI |
M0028852 |
Scope note | A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. |
Preferred term | Alendronate |
Entry term(s) |
4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate Aminohydroxybutane Bisphosphonate |
Concept UI |
M0028851 |
Preferred term | MK-217 |
Entry term(s) |
MK 217 MK217 |
Concept UI |
M000638656 |
Preferred term | Alendronate Monosodium Salt, Trihydrate |
Concept UI |
M0329075 |
Preferred term | Alendronate Sodium |
Concept UI |
M0028853 |
Preferred term | Fosamax |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey